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Objective: Arrhythmogenic right ventricular cardiomyopathy (ARVC) is associated with
remodeling of gap junctions and also, although less well-deﬁned, down-regulation of the
fast sodium current. The gap junction remodeling and down-regulation of sodium current
have been proposed as contributors to arrhythmogenesis in ARVC by slowing conduction.
The objective of the present study was to assess the amount of conduction slowing due
to the observed gap junction remodeling and down-regulation of sodium current. Meth-
ods:The effects of (changes in) gap junctional conductance, cell dimensions, and sodium
current on both longitudinal and transversal conduction velocity were tested by simulating
action potential propagation in linear strands of human ventricular cells that were either
arranged end-to-end or side-by-side. Results: A 50% reduction in gap junction content, as
commonly observed in ARVC, gives rise to an 11% decrease in longitudinal conduction
velocity and a 29% decrease in transverse conduction velocity. A down-regulation of the
sodium current through a 50% decrease in peak current density as well as a −15mV shift in
steady-state inactivation, as observed in an experimental model of ARVC, decreases con-
duction velocity in either direction by 32%. In combination, the gap junction remodeling
and down-regulation of sodium current result in a 40% decrease in longitudinal conduc-
tion velocity and a 52% decrease in transverse conduction velocity. Conclusion:The gap
junction remodeling and down-regulation of sodium current do result in conduction slow-
ing, but heterogeneity of gap junction remodeling, in combination with down-regulation
of sodium current, rather than gap junction remodeling per se may be a critical factor in
arrhythmogenesis in ARVC.
Keywords: arrhythmogenic right ventricular cardiomyopathy, cardiac arrhythmias, cardiac electrophysiology,
cardiac myocytes, computer simulations, connexin43, gap junctions, sodium channels
INTRODUCTION
Arrhythmogenic right ventricular cardiomyopathy (ARVC), also
known as arrhythmogenic right ventricular dysplasia (ARVD)
or arrhythmogenic right ventricular dysplasia/cardiomyopathy
(ARVD/C), is an inheritable arrhythmogenic disease character-
ized by ventricular tachyarrhythmias and sudden cardiac death.
These occur mostly in the early “concealed” phase of the disease,
in the absence of the extensive structural damage, including the
ﬁbro-fatty replacement of the myocardium, that characterizes the
later phases. These and other characteristics of ARVC have been
reviewed in detail elsewhere (Thiene et al., 2007; Basso et al., 2009,
2012; Sen-Chowdhry et al., 2010; Sen-Chowdhry and McKenna,
2012). The disease does not only occur in humans, but has also
been described for cats (Fox et al., 2000; Harvey et al., 2005), dogs
(Basso et al., 2004; Oxford et al., 2011), and horses (Freel et al.,
2010).
Initially, ARVC was considered to be a developmental defect
of the right ventricular myocardium, explaining the original term
dysplasia, which was replaced once it was recognized that ARVC
was not a structural defect present at birth. Furthermore, it became
clear that the disease is not restricted to the right ventricle, but
may also be biventricular or even left-dominant, leading to the
introduction of the broader term arrhythmogenic cardiomyopa-
thy (Basso et al., 2009, 2012; Sen-Chowdhry et al., 2010), abbrevi-
ated to AC by Basso et al. (2012), but, referring to a recent “Expert
Consensus Statement,” to ACM by Jacoby and McKenna (2012).
The latter authors,however, also use the termarrhythmogenic ven-
tricular cardiomyopathy (AVC). Here, we will use the term ARVC,
although we are aware that the disease may also affect the left
ventricle.
A common observation in ARVC is remodeling of cardiac gap
junctions early in the disease, with a diminished expression of the
major gap junction protein connexin43 (Cx43) at the intercalated
disks (IDs),which establish the mechanical and electrical coupling
between adjacent cells (Safﬁtz, 2009). In samples from a single
early-stage patient with Naxos disease, a rare variant of ARVC
caused by a recessive mutation in the JUP gene encoding plako-
globin, electron microscopy revealed 2–5 times smaller and 1.5–4
times fewer gap junctions between both left and right ventricular
myocytes as compared to left ventricular control samples (Kaplan
et al., 2004). Of note, we have previously demonstrated that the
number of gap junctions is more important for net intercellular
coupling than gap junction size (Jongsma and Wilders, 2000). In
another electron microscopic study, Basso et al. (2006) found a
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2.5-fold reduction in number, but not length, of gap junctions
at the IDs in right ventricular biopsies from 21 ARVC patients
as compared to controls. In Boxer dogs with ARVC, a signiﬁ-
cant reduction in number, but again not length, of gap junctions
between both left and right ventricular myocytes was observed
(Oxford et al., 2011). The median number of gap junctions per
10μm of ID, as revealed by electron microscopy, was reduced by
a factor of 2 in the left ventricle and by a factor of 3 in the right, as
compared to non-ARVCdogs,with a large variation in thismedian
number between ARVC dogs.
In the young, i.e., in people aged ≤35 years, ARVC is a lead-
ing cause of sudden cardiac death, which is often the ﬁrst clinical
manifestation of the disease (see Sen-Chowdhry et al., 2010; and
primary references cited therein). The prevalence of ARVC is com-
monly estimated to vary from 1:2,000 to 1:5,000 (Basso et al.,
2012),but a higher prevalence has also been suggested (Peters et al.,
2004; Lahtinen et al., 2011). In 50–60% of clinically diagnosed
ARVC patients one or more mutations in desmosomal protein
genes, like the aforementioned JUP gene, are found (Bhuiyan et al.,
2009; den Haan et al., 2009; Kapplinger et al., 2011). These muta-
tions particularly occur in PKP2, encoding plakophilin-2 (PKP2),
which is known to interact with other molecules of the IDs. Using
RNA silencing techniques to decrease the expression of PKP2 in
cardiac cells, Oxford et al. (2007) demonstrated that Cx43 and
PKP2 are part of a common macromolecular complex and that a
loss of PKP2 expression leads to loss of gap junction plaques and
a decrease in intercellular coupling as assessed by dye transfer. In a
subsequent study on cultured cardiomyocytes (Sato et al., 2009), it
was shown that PKP2 associates with the SCN5A encoded sodium
channel protein NaV1.5 and that knockdown of PKP2 expression
alters the properties of the sodium current. Patch clamp studies
revealed a decrease in peak current density by ≈50%, a −15 to
−20mV shift in the steady-state inactivation curve, and a slowed
recovery from inactivation, all reducing membrane excitability.
Given the strong association in expression levels of Cx43 and
NaV1.5 observed in recent studies (Desplantez et al., 2012; Jansen
et al., 2012), the decrease in peak current density may be directly
related to the decrease in intercellular coupling. Further evidence
for the involvement of sodium current in ARVC comes from a
recent study by Gomes et al. (2012), who studied right ventricular
biopsies from three ARVC patients and observed NaV1.5 mislo-
calization in biopsies from two early-stage patients. On the other
hand, in the same study no difference was observed in sodium
current properties in a desmoplakin+/− murine model of ARVC,
despite a reduced Cx43 expression at the IDs.
Although ARVC is associated with a clear reduction in intercel-
lular coupling andprobably also inmembrane excitability,which is
largely determined by the fast sodiumcurrent, it remains question-
ablewhether the observed changes, either alone or in combination,
can explain the arrhythmogenic nature of early-stage ARVC. The
aim of the present study is to assess the functional implications of
the ARVC related gap junction remodeling and down-regulation
of sodium current in human ventricle. To this end, we carried
out computer simulations using linear strands of cardiac cells,
which were either arranged end-to-end or side-by-side. Individ-
ual cells of the strand were described by a mathematical model
of a human (left) ventricular cell. After deﬁning “normal” gap
junctional conductance, based on data from literature, we tested
the effects of (changes in) gap junctional conductance, myoplas-
mic resistivity, cell dimensions, and sodiumcurrent on conduction
velocity in these strands.
Our simulation results show that conduction velocity is only
moderately sensitive to changes in gap junctional conductance,
cell length, cell width, or sodium current per se. The combined
effects of gap junction remodeling anddown-regulationof sodium
current are larger, but still not deﬁnitely arrhythmogenic, sug-
gesting that heterogeneity of gap junction remodeling rather
than gap junction remodeling itself may be a critical factor in
arrhythmogenesis, in particular if it occurs in combination with
down-regulation of sodium current.
MATERIALS AND METHODS
LINEAR STRAND MODEL
Action potential conduction is studied in a linear strand of 90 cells
that are either arranged end-to-end (Figure 1A) or side-by-side
(Figure 1B) and coupled by an ohmic gap junctional conductance
g j. For each cell in the strand, ionic currents, and concentration
changes are computed using the human ventricular cell model by
Priebe and Beuckelmann (1998). This model is based on the Luo-
Rudy dynamic model of the guinea pig-type ventricular action
potential (Luo and Rudy, 1994), but equations for ionic currents
and calciumhandling have beenmodiﬁed to account for data from
isolated human ventricular cells (Priebe and Beuckelmann, 1998).
A propagating action potential is elicited by applying a 2-ms, 20–
25% suprathreshold stimulus to the leftmost cell of the strand at
1Hz. Conduction velocity is computed across the middle third of
the strand.
Myoplasmic speciﬁc resistance (myoplasmic resistivity; ρmyo)
is set to 150Ω cm. To allow comparison between g j and ρmyo, we
compute the gap junctional resistivity ρj by “spreading out” g j
across the length – or width, in case of transverse conduction – of
FIGURE 1 | Diagram of linear strand model.The strand is composed of
90 human ventricular cells, coupled by an ohmic gap junctional conductance
g j . Myoplasmic resistivity is set to 150Ω cm. Action potential propagation is
initiated by applying an external stimulus to the leftmost cell of the strand.
(A) Cells arranged longitudinally. (B) Cells arranged transversally.
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the cell. Thus, for longitudinal conduction, we have ρj =A/(g j·l),
where A denotes the 19.5-μm2 × 19.5-μm2 cross-sectional area
and l denotes the 100-μm cell length. Total resistivity in the
direction of conduction is computed as the sum of ρmyo and ρj.
In simulations with an increase in cell length or cell width, the
membrane current densities were kept constant.
NUMERICAL METHODS
Since earlier simulations have shown that subcellular discretiza-
tion is not required for accurate computation of conduction veloc-
ity (Shaw and Rudy, 1997), we use entire cells as computational
elements with ρmyo and ρj lumped together at each discretiza-
tion point. No-ﬂux boundary conditions are used at both ends of
the strand. Stimulation and termination artifacts are restricted to
≈5 cells from both ends. For numerical integration of differential
equations we applied a simple and efﬁcient Euler-type integration
scheme (Rush and Larsen, 1978) with a 1-μs time step. All soft-
warewas compiled as a 32-bitWindows application usingCompaq
Visual Fortran 6.6C and run on an Intel Xeon processor based
workstation.
RESULTS
“NORMAL” GAP JUNCTIONAL CONDUCTANCE
Before assessing the effects of a reduction in g j, we need to deﬁne
a control value of g j, both for side-by-side and end-to-end cou-
pled cells. Studies on isolated cell pairs report widely different
values for the gap junctional conductance between adult mam-
malian ventricular cells, ranging from 5 nS to 4 μS, as summarized
by Wilders and Jongsma (1992). Most likely, each of these values
is an underestimate of true gap junctional conductance, because
these pairs consist of cells that have not become completely sep-
arated during the enzymatic isolation procedure to which they
were subjected. Therefore, we chose another approach to esti-
mate “normal” g j, using data from confocal microscopy studies.
In normal human left ventricular myocardium, mean gap junc-
tion plaque area is 0.21 μm2 (Kaprielian et al., 1998). For such gap
junctions, effective gap junctional conductance is ≈0.6μS/μm2
(Jongsma and Wilders, 2000). Gap junction labeling is conﬁned to
IDs in normal human left ventricle, and gap junction surface den-
sity is 0.0051–0.0055μm2/μm3 (Peters et al., 1993; Kostin et al.,
2003). Combining these numbers with the human left ventricu-
lar myocyte volume of 27,947μm3 (Zafeiridis et al., 1998) and
the total of 11.55 IDs per myocyte (Peters et al., 1993), which
implies – given that left ventricular myocytes are connected to
11.3± 2.2 neighbors (Kanno and Safﬁtz, 2001) – that neighboring
myocytes are typically connected by a single ID,which provides an
intercellular pathway with an effective conductance of ≈7.7μS.
From the above, our round estimate for normal g j in case
of longitudinal conduction would be 8 μS. Since gap junctions
are largely conﬁned to IDs in normal ventricular myocardium, a
similar estimate would hold for transverse conduction. Figure 2
shows longitudinal and transverse conduction velocity (θL and θT,
respectively) in the strands of Figure 1 as a function of g j, which is
varied between 10 nS and 20 μS. The value of 10 nS is about twice
the minimum value of 5.4 nS required for successful action poten-
tial conduction (with θL and θT values as low as 0.5 and 0.1 cm/s,
respectively). The g j value of 8μS results in θL and θT values of
FIGURE 2 | Relation between conduction velocity and gap junctional
conductance for the strands of Figure 1.
67 and 26 cm/s, respectively. The longitudinal conduction veloc-
ity of 67 cm/s agrees well with the control value of 65± 4 cm/s
(mean± SEM, n = 7) for planar wave propagation in longitudi-
nal direction in human left ventricular myocardium reported by
Taggart et al. (2000).
Now that we have deﬁned “normal” g j, we can determine the
decrease in conduction velocity upon a 50%or even larger decrease
in g j as observed in ARVC (see Introduction) or the 25–50%
decrease as observed in various other cardiomyopathies (Smith
et al., 1991; Peters et al., 1993; Kaprielian et al., 1998; Dupont et al.,
2001; Kostin et al., 2003). A 25–50% decrease in g j from 8 to 4–
6μS results in a 4–11% decrease in θL from 67 to 60–64 cm/s and
a 13–29% decrease in θT from 26 to 19–23 cm/s (Figure 2). These
effects may be considered moderate. However, larger effects are
observed upon a 75% decrease in g j to 2μS, which may reﬂect
the remodeling that occurs in ARVC. Then, θL and θT decrease to
50 and 13 cm/s, respectively, i.e., a 25% decrease in θL and a 50%
decrease in θT (Figure 2).
From Figure 2, it can also be appreciated that θL tends to
“saturate” near 70 cm/s with increasing g j, whereas θT is more
steeply dependent on g j. The relative insensitivity of θL to g j can
be explained in terms of the gap junctional resistivity ρj (see Mate-
rials and Methods). To this end, we have plotted ρj as a function
of g j in Figure 3A. For longitudinal conduction, ρj falls below the
myoplasmic resistivity of 150Ω cm (horizontal dashed line) at a
gap junctional conductance as low as 2.5 μS, whereas for trans-
verse conduction ρj is considerably larger than ρmyo at all values
of g j. At the normal g j of 8μS, gap junctions are responsible for
only 24% of total resistivity in the longitudinal direction, whereas
this number is 89% in the transverse direction (Figure 3B).
CONDUCTION VELOCITY AND CELL DIMENSIONS
“Myocyte atrophy” is a common observation in ARVC (Gomes
et al., 2012), but quantitative data are scarce. In a study with
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FIGURE 3 | Relation between gap junctional resistivity and gap
junctional conductance for longitudinal (circles) or transverse
arrangement of cells (squares). (A) Gap junctional resistivity in Ω·cm.
Dashed horizontal line indicates the myoplasmic resistivity of 150Ω cm.
Note logarithmic ordinate scale. (B) Gap junctional resistivity expressed as
percent of total resistivity.
transgenic mice overexpressing a desmoplakin mutant gene, Yang
et al. (2006) observed that ventricular cardiomyocyte cross-
sectional areas were 40% higher in mutant mice as compared to
control mice. Changes in cell dimensions are not limited to ARVC.
Both hypertrophy and heart failure are associated with changes
in myocyte dimensions. Length and width of failing human left
ventricular myocytes are increased by 48 and 20%, respectively
(Zafeiridis et al., 1998). Similarly, failing rabbit left ventricular
myocytes show an increase by 39 and 50%, respectively (de Groot
et al., 2003). Left ventricular myocytes from patients with ischemic
heart disease show a 49% increase in length-to-width ratio with-
out a signiﬁcant change in cell width (Gerdes et al., 1992). To
test to which extent an increase in myocyte length or width adds
to changes in conduction velocity, simulations were run with
myocyte length or width increased by 50%. Results are shown
in Figure 4. Note that, for reasons of clarity, a descending abscissa
scale is used in this and subsequent ﬁgures.
An increase in cell length has a beneﬁcial effect on θL, because
the number of gap junctions per unit distance decreases. How-
ever, the effect is small at high g j (Figure 4A) because the strand
is then essentially a uniform cable with a total resistivity that is
largely determined by the resistivity of the myoplasm (Figure 3B).
At very low values of g j (<30 nS), at which propagation is slow
and discontinuous, θL is considerably depressed by the increase in
cell length. The time required to supply enough current, by the
combination of sodium and L-type calcium current, to the down-
stream cell to reach threshold is then increased by>50%. Loading
effects also play a role in case of transverse conduction (Figure 4B).
If cell length is increased without a concomitant increase in g j,
the increased load of the downstream cells hampers conduction,
resulting in reduced θT.
Opposing effects on θL are observed upon an increase in cell
width (Figure 4C). The increased cross-sectional area of the cells
reduces the intracellular resistance per unit of distance, thus facil-
itating intracellular current ﬂow, but on the other hand more
excitatory current is required due to the increased membrane sur-
face area. At 4μS, the two effects cancel out, but at the normal
g j of 8μS, θL is increased by 8%. For transverse conduction, the
decrease in the number of gap junctions per unit distance upon an
increase in cell width results in increased θT (Figure 4D) despite
the increased downstream load. Only if g j is very low (<30 nS), θT
is considerably depressed by a>50% increase in conduction time.
According to our simulation results, a 20% increase in cell width
(or cell radius), as suggested by the aforementioned 40% increase
in ventricular cardiomyocyte cross-sectional area in a transgenic
mouse model of ARVC (Yang et al., 2006), would not contribute
to the ARVC related conduction slowing, but rather increase con-
duction velocity. Additional simulations show that a 20% increase
in cell width increases θL by 5% to 70 cm/s and increases θT by 9%
to 28 cm/s.
CONDUCTION VELOCITY AND MYOPLASMIC RESISTIVITY
Our simulation results so far suggest that myoplasmic resistivity is
an important determinant of (longitudinal) conduction velocity.
To test to which extent this model parameter affects simulation
results, we computed conduction velocity at ρmyo values that are
higher or lower than our model value of 150 Ω cm. If ρmyo is raised
to 250Ω cm, θL is reduced at all values of g j (by 20% at 8μS) and it
eventually “saturates” at ≈59 cm/s. If ρmyo is lowered to 100Ω cm,
θL increases at all values of g j (by 17% at 8μS; Figure 5A) and
eventually “saturates” at ≈96 cm/s (not shown). Effects on θT are
minimal, as expected from the large contribution of gap junctional
resistivity (Figure 3), with a<4% change at 8μS (Figure 5B).
Given the dependence of (longitudinal) conduction velocity on
myoplasmic resistivity, it is important to document the selection
of the model value for this parameter. With typical values of 150
(Shaw and Rudy, 1997; Kucera et al., 2002), 200 (Rudy and Quan,
1987), and 250Ω cm (Spach et al., 2000), our value of 150Ω cm
is at the lower end of the range of values used in these and sub-
sequent theoretical studies, but near the experimentally observed
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FIGURE 4 | Effect of changes in cell dimensions on conduction velocity.
(A,B) Effect of 50% increase in cell length on (A) longitudinal and (B)
transverse conduction velocity. (C,D) Effect of 50% increase in cell width on
(C) longitudinal and (D) transverse conduction velocity.
value of 166± 19Ω cm (mean± SEM,n = 11) at 35˚C (Kléber and
Riegger, 1987). Impedance measurements on guinea pig left ven-
tricular myocardium yield a value of 100± 9Ω cm (mean± SEM,
n = 31) at 37˚C (Cooklin et al., 1997), which is only two times
the value of 49± 1Ω cm for the resistivity of Tyrode solution (Sui
et al., 2003).
CONDUCTION VELOCITY AND MEMBRANE EXCITABILITY
Conduction velocity is not only determined by the passive charac-
teristics of the cardiac cell network that constitutes the substrate
for impulse propagation, but also by the active properties of the
cardiac cell membrane, in particular of the fast sodium current
(INa). It is likely that the expression of sodium channels is reduced
in ARVC (see Introduction), with a decrease in current density of
INa of ≈50% (Sato et al., 2009). A down-regulation of INa has
not only been implicated in ARVC. For example, a 32% reduction
in INa conductance was observed in isolated ventricular myocytes
from dogs with chronic heart failure (Maltsev et al., 2002).
To gain insight into the role of INa in determining conduction
velocity, we ran simulations with the number of sodium channels
increased or decreased by 50%, which was accomplished by a 50%
increase or decrease in the fully activated INa conductance (gNa),
respectively. The increased excitability results in an increase in both
θL and θT.At the normal g j of 8μS,θL and θT are both increased by
24%. Similarly, halving gNa results in a 22–23% decrease in both
θL and θT (Figure 6).
MAJOR DETERMINANTS OF CONDUCTION VELOCITY
In the above, we have investigated how conduction velocity is
related to structural determinants of conduction (gap junctional
conductance, myocyte dimensions, myoplasmic resistivity) and
active membrane properties (conductance of INa). In Figure 7,
we compare their relative importance at different levels of inter-
cellular coupling. We have determined the relative change in θL
and θT in response to a plus or minus 50% change in gap junc-
tional conductance, cell length, cell width, myoplasmic resistivity,
and INa conductance at g j values of 2, 4, 8, and 12μS.
Several conclusions can be drawn from Figure 7. (1) None of
the changes exerts a 1:1 effect on conduction velocity: the change in
conduction velocity upon a 50% change in any of the parameters
is always <50%. (2) For transverse conduction (bottom panels),
the effects at 2, 4, 8, and 12μS are largely similar. (3) The effects
of changes in active membrane properties (conductance of INa)
are almost identical for longitudinal and transverse conduction
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FIGURE 5 | Dependence on myoplasmic resistivity (ρmyo) of relationship
between (A) longitudinal or (B) transverse conduction velocity and
gap junctional conductance.
and relatively constant over the range of g j values examined. (4)
Gap junctional conductance is not the single major determinant
of conduction velocity. At normal g j,myocyte dimensions and INa
conductance are equally important.
Figure 7A shows an interesting phenomenon occurring at
g j = 2μS. The longitudinal strand then operates at an optimum
cell width: both an increase and a decrease in cell width result in a
decrease in θL. This phenomenon is related to the opposing effects
on θL of changes in cell width,which also underlie the“cross-over”
at 4μS in Figure 4C.
CONDUCTION VELOCITY IN ARVC
In ARVC, the number of gap junctions may be decreased by 50%
while at the same time sodium current is down-regulated. The
study by Sato et al. (2009) shows that the sodium current density
may be decreased by ≈50%, whereas the steady-state inactivation
FIGURE 6 | Effect of halving or doubling sodium current (INa)
conductance on (A) longitudinal and (B) transverse conduction
velocity.
curve may be shifted in the negative direction by 15–20mV.
Therefore, we also assessed the combined effects of changes in
intercellular coupling and sodium current, using 8 μS as the con-
trol value for gap junctional conductance. Figure 8 displays the
separate effects of a 50% reduction in gap junctional conductance,
a 50% reduction in INa conductance, and a −15mV shift in the
steady-state inactivation curve of INa on both θL (Figure 8A) and
θT (Figure 8B). The combined effects of the reduction in INa
conductance and shift in inactivation curve are also shown. The
rightmost bars show θL (Figure 8A) and θT (Figure 8B) under
ARVC like conditions, i.e., if the intercellular coupling is reduced
by 50% and the sodium current is down-regulated through a 50%
decrease in current density as well as a−15mV shift in steady-state
inactivation.
The 50% decrease in gap junctional conductance reduces θL
by 11% and θT by 29%, again demonstrating that transverse
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FIGURE 7 | Percent change in longitudinal (top) and transverse conduction velocity (bottom) upon −50% or +50% change in gap junctional
conductance (g j), cell length, cell width, myoplasmic resistivity (ρmyo), or sodium current conductance (gNa). (A) g j =2μS. (B) g j =4μS. (C) g j =8μS. (D)
g j =12μS.
conduction is more sensitive to gap junctional conductance than
longitudinal conduction. The 50% decrease in INa conductance
reduces θL by 22% and θT by 23%, whereas the −15mV shift
in steady-state inactivation reduces both θL and θT by 9%. In
combination, the decrease in INa conductance and shift in inacti-
vation result in a 32% decrease in both θL and θT. Under ARVC
like conditions, not taking into account a potential change in cell
dimensions, θL and θT are decreased by 40 and 52%, respectively.
We have also run simulations in which the ARVC like condi-
tions were extended with a tentative 20% increase in cell width
(or cell radius), as suggested by the 40% increase in ventricular
cardiomyocyte cross-sectional area in a transgenic mouse model
of ARVC (Yang et al., 2006). With a 39% decrease in θL instead of
the above 40%, the effect on θL is small, as might be expected from
the “cross-over” at 4μS in Figure 4C. The effect on θT is larger,
with a decrease in θT of 48% instead of the above 52%.
DISCUSSION
We used computer simulations to assess the functional implica-
tions of gap junction remodeling and down-regulation of INa,
as implicated in ARVC. We investigated how conduction veloc-
ity is related to both structural determinants of conduction (gap
junctional conductance, cell length and width, myoplasmic resis-
tivity) and active membrane properties (conductance and kinetics
of sodium current). Our simulation results show that the slow-
ing effects of gap junction remodeling per se are only moderate
and that conduction may be more sensitive to changes in mem-
brane excitability, i.e., in INa, which is line with experimental
data obtained from mouse models of reduced excitability or
intercellular coupling (Stein et al., 2011). Our data also show that
θT is more sensitive to changes in g j than θL, which agrees with
experimental studies in which uncoupling agents were used to
induce a uniform reduction in g j (see Dhein et al., 1999; and
primary references cited therein).
MODEL PARAMETERS
We have used a control value of 8μS for the gap junctional con-
ductance between ventricular cells. This value is higher than values
that have been used in previous simulation studies, e.g., 0.77 μS
(Spach et al., 2000) and 2.5μS (Shaw and Rudy, 1997; Kucera
et al., 2002). Our value is, however, based on data from literature
and yields a value for longitudinal conduction velocity that is in
accordance with data from human ventricle as obtained by Taggart
et al. (2000). The θL value of 67 cm/s may seem somewhat large
compared to the mean value of ≈56 cm/s obtained from “classic”
animal studies as summarized by Kléber et al. (2001). However,
more recent studies typically show θL values near 65 cm/s inmouse
(Gutstein et al., 2001a), guinea pig (Girouard et al., 1996), and dog
(Watanabe et al., 2000).
Our myocyte dimensions follow from the single human ven-
tricular cell model we employed (Priebe and Beuckelmann,
1998), which in turn uses the same dimensions as the Luo-
Rudy model of a guinea pig-type ventricular myocyte (Luo and
Rudy, 1994). The model values for myocyte length (100μm) and
width (≈20μm) are small compared to the values of 136± 4
and 26.2± 1.3μm (mean± SEM, n = 210), respectively, reported
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FIGURE 8 | Effect of a 50% decrease in gap junctional conductance
(labeled “g j ↓”), a 50% decrease in sodium current conductance (“gNa
↓”) or a −15mV shift in the INa steady-state inactivation curve
(“shift”), as implicated in ARVC, on (A) longitudinal and (B) transverse
conduction velocity. Also shown are the combined effects of a 50%
decrease in gNa and a −15mV shift (“gNa ↓ and shift”) and the combined
effects of a 50% decrease in g j , a 50% decrease in gNa and a −15mV shift
(“ARVC”).
for human ventricular myocytes (Zafeiridis et al., 1998), which
are similar to the dimensions reported for guinea pig and rabbit
myocytes (Cooklin et al., 1997; de Groot et al., 2003; Wiegerinck
et al., 2006). The apparent underestimation of cell length and
width does not affect the simulation results to a large extent. A
30% increase in the control values for both cell length and width,
tomatch these experimental data, increases θL by 9%anddecreases
θT by 1% (data not shown).
Our simulation results identify myoplasmic resistivity as an
important determinant of θL, but not θT. Unfortunately, this para-
meter is difﬁcult to determine experimentally (see, Kléber and
Riegger, 1987). As mentioned above, the model value of 150Ω cm
is at the lower end of values used in simulation studies. However,
if we had for example set ρmyo to 250Ω cm, θL would have been
limited to values below 60 cm/s, irrespective of the value of g j
(Figure 5A). On the other hand, our value of 150Ω cm is in
line with a simulation study of propagation in synthetic strands
of cultured neonatal ventricular myocytes, in which the ﬁt to
experimental data required a myoplasmic resistivity of 124Ω cm
(Thomas et al., 2003).
LIMITATIONS
In this study, we have assessed action potential propagation in
linear strands with a simple and uniform arrangement of cells
within the strands. Such reconstruction represents the propaga-
tion of broad planar wavefronts, either on the myocardial surface
or transmurally, from endocardium to epicardium, during nor-
mal ventricular excitation. Thus, the complex architecture of the
cardiac syncytium is much simpliﬁed and some important deter-
minants of cardiac activation, including current-to-loadmismatch
(Derksen et al., 2003) and wavefront curvature (Fast and Kléber,
1997; Chow et al., 2002), have been excluded from our analy-
sis. In particular, enhanced anisotropy may have an attenuating
effect on the reduction in longitudinal conduction velocity in case
of impaired membrane excitability and intercellular coupling by
forcing intercellular current ﬂow in the axial direction (Wilders
et al., 2000; Stein et al., 2009).
We have used the human ventricular cell model by Priebe and
Beuckelmann (1998). This model dates from the late 1990s, but
seems suited for the present study that focuses on generic proper-
ties of cardiac tissue. Notably, the cell dimensions and the sodium
current equations are identical to those of the original and updated
versions of the Luo-Rudy dynamic model of mammalian subepi-
cardial ventricular myocytes that we and others employed in more
recent studies (Wiegerinck et al., 2006; Petitprez et al., 2008; Gaur
et al., 2009). Although our simulations are of a generic nature, we
cannot exclude that our results and conclusions are to some extent
dependent on the chosen ventricular cell model.
We have subjected our simulated strands to relatively “mild”
ARVC related conditions. First, gap junctional conductance and
sodium current conductance have been reduced by 50%, whereas
the actual reduction may be larger. Second, we have limited the
shift in the steady-state INa inactivation curve to −15mV,whereas
the actual shiftmay be as large as−20mV (Sato et al., 2009). Third,
we have not investigated the effects of high frequency stimulation
or the experimentally observed prolongation in the recovery from
INa inactivation (Sato et al., 2009), which may both impair con-
duction. Indeed, preliminary simulations with 2-Hz stimulation
and a −20mV shift in inactivation result in 2:1 conduction block,
both longitudinally and transversally (data not shown). The lat-
ter results underscore the potentially important role of sodium
current kinetics in ARVC rather than gap junctional conductance
or INa density, as do the simulation results of Deo et al. (2011).
It should, however, be noted that a direct comparison with the
study by Deo et al. (2011) is not possible, because this study
aimed at simulating conduction in a two-dimensional isotropic
monolayer of rat ventricular myocytes with a conduction velocity
of ≈25 cm/s.
Frontiers in Physiology | Cardiac Electrophysiology May 2012 | Volume 3 | Article 168 | 8
Wilders ARVC: considerations from in silico experiments
IMPLICATIONS FOR ARRHYTHMOGENESIS
Although a causative role in vivo remains speculative, gap junction
remodeling has been postulated to contribute to the increased
propensity for arrhythmogenesis in the diseased myocardium
of ARVC patients. Gap junction remodeling could potentially
induce signiﬁcant slowing of conduction, thereby facilitating
micro-reentrant arrhythmias. However, our simulation results
demonstrate that a 50% reduction in gap junctional conduc-
tance, as expected from the ≈50% reduction in Cx43 expression
in diseased hearts, gives rise to relatively small changes in con-
duction velocity. In line with these simulation results, Cx43+/−
mice, which show a ≈50% decrease in Cx43 expression, are not
prone to arrhythmias, as tested by subjecting them to aggressive
extra-stimulation protocols (Thomas et al., 1998; Vaidya et al.,
2001).
Given the relatively small effects of gap junctional remodeling
on conduction velocity, other factors, like (changes in) membrane
excitability and cell dimensions, come into play as contributors
to arrhythmogenesis. However, our simulations demonstrate that
neither the observed decrease in sodium current density, as a main
determinant of membrane excitability, nor the observed increase
in myocyte cross-sectional area would give rise to highly signiﬁ-
cant changes in conduction velocity. As discussed above, changes
in sodium current kinetics, rather than gap junctional conduc-
tance or sodium current density, may play an important role in
the arrhythmogenesis of ARVC. In particular, incomplete recovery
from inactivation during extra-stimuli and premature beats may
play an important role in triggering ARVC related arrhythmias.
The prediction from our model that a 50% decrease in Cx43
levels would not have a major effect on conduction velocity may
seem to question the idea that a reduced Cx43 expression con-
tributes to the arrhythmogenesis of ARVC. However, it should be
kept inmind – as a commonobservation that seems also applicable
to ARVC – that the extent of Cx43 reduction may vary consider-
ably between patients, sometimes reaching a reduction of>90%of
control values, where conduction velocity becomes steeply depen-
dent on gap junctional conductance (Figure 2), and that such
reduction is often superimposed on heterogeneity of Cx43 dis-
tribution (Dupont et al., 2001; Severs, 2001). A high degree of
cellular uncoupling may occur locally without affecting global
conduction characteristics, and may predispose to the formation
of unidirectional block and reentry. This is in line with the obser-
vation that Cx43−/− conditional knockout mice, which show a
large and heterogeneous decrease in Cx43 expression but only a
moderate decrease in conduction velocity, are extremely prone to
arrhythmias (Gutstein et al., 2001a; van Rijen et al., 2004), and
with the observation of conduction defects in a murine model of
heterogeneous gap junction channel expression (Gutstein et al.,
2001b). If heterogeneity of gap junction remodeling occurs in
combination with down-regulation of sodium current, it may cre-
ate the substrate for the ventricular tachyarrhythmias observed
in ARVC.
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